T1 Condition 1270 1275 tumor
T2 Protein 400 408 post‐RCT
T3 Condition 883 888 tumor
T4 Condition 821 826 tumor
T6 Protein 450 460 E‐cadherin
T7 Organism 222 230 patients
T8 Intervention 487 502 solid glandular
T9 Condition 1069 1074 tumor
T10 Condition 236 249 rectal cancer
T11 Condition 821 834 tumor samples
T12 Intervention 859 875 primary biopsies
T14 Protein 1125 1139 tumor‐specific
T15 Protein 1325 1343 E‐cadherin protein
T16 Condition 346 363 RCT and 213 tumor
T17 Condition 465 470 tumor
T18 Gene 1034 1054 Post‐RCT single‐cell
T19 Condition 1125 1130 tumor
T20 Intervention 1424 1434 metastases
T21 Intervention 1375 1381 biopsy
T22 Protein 1497 1505 post‐RCT
T23 Intervention 925 931 biopsy
T24 Condition 94 99 tumor
T25 Protein 1270 1284 tumor‐specific
T26 Intervention 164 193 neoadjuvant radiochemotherapy
T27 Intervention 552 558 tissue
T28 Condition 997 1002 tumor
T29 Condition 1598 1603 tumor
T30 Protein 45 55 E‐cadherin
T31 Protein 428 435 Protein
T32 Organism 1692 1710 high‐risk patients
T33 Condition 1385 1398 rectal cancer
T34 Protein 997 1011 tumor‐specific
T35 Condition 130 143 rectal cancer
T36 Cellular_component 1497 1524 post‐RCT resection specimen
T37 Protein 703 713 E‐cadherin
T38 Protein 1325 1335 E‐cadherin
T39 Protein 896 906 E‐cadherin
